NCPA urges Pennsylvania lawmakers to support pharmacy audit bill
In a letter to Pennsylvania state lawmakers, the National Community Pharmacists Association urged the leaders to support legislation concerning pharmacy audits.
In a letter to Pennsylvania state lawmakers, the National Community Pharmacists Association (NCPA) urged the leaders to support legislation concerning pharmacy audits.
H.B. 727 would set fair and common sense protections for community pharmacies against abusive auditing practices by pharmacy benefit managers, according to NCPA’s letter.
“This important legislation is based on a simple principle: When a pharmacist dispenses the right medication to the right patient at the right time, as prescribed by a doctor, it should not be a punishable offense,” said NCPA CEO B. Douglas Hoey, RPh, MBA. “Pharmacists recognize the need for legitimate audits to protect public and private health plans from waste, fraud, and abuse. However, pharmacy-auditing practices are out of control. Time-consuming, abusive audits compromise pharmacists’ availability to counsel patients. Increasingly, they appear to be more about generating revenue for the middleman than rooting out fraud.”
If Pennsylvania joins the movement to pass the bill, it would be among 23 other states that have enacted similar laws to protect their small businesses.
Unlock the Benefits of Centralized Fulfillment for Pharmacists: A Comprehensive Guide
November 6th 2024Streamline your pharmacy operations with centralized fulfillment. Discover how automation and advanced software can improve patient care, reduce operational errors, and create a better work environment for pharmacists. Download our whitepaper to learn how centralized fulfillment can address rising prescription volumes and staffing shortages. Request a consultation today to explore the best solution for your pharmacy.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
